UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Neurofilament ELISA validation

Petzold, A; Altintas, A; Laura, C; Bartos, A; Achim, F; Blankenstein, MA; Luc, H; ... Teunissen, CE; + view all (2010) Neurofilament ELISA validation. J IMMUNOL METHODS , 352 (1-2) 23 - 31. 10.1016/j.jim.2009.09.014. Green open access

[img]
Preview
PDF
nf-validation-PR-v6.pdf
Available under License : See the attached licence file.

Download (279kB)

Abstract

Background: Neurofilament proteins (Nf) are highly specific biomarkers for neuronal death and axonal degeneration. As these markers become more widely used, an inter-laboratory validation study is required to identify assay criteria for high quality performance.Methods: The UmanDiagnostics NF-light (R) enzyme-linked immunoabsorbent assays (ELISA) for the neurofilament light chain (NfL, 68 kDa) was used to test the intra-assay and inter-laboratory coefficient of variation (CV) between 35 laboratories worldwide on 15 cerebrospinal fluid (CSF) samples. Critical factors, such as sample transport and storage, analytical delays, reaction temperature and time, the laboratories' accuracy and preparation of standards were documented and used for the statistical analyses.Results: The intra-laboratory CV averaged 3.3% and the inter-laboratory CV 59%. The results from the test laboratories correlated with those from the reference laboratory (R = 0.60, p < 0.0001). Correcting for critical factors improved the strength of the correlation. Differences in the accuracy of standard preparation were identified as the most critical factor. Correcting for the error introduced by variation in the protein standards improved the correlation to R = 0.98, p < 0.0001 with an averaged inter-laboratory CV of 14%. The corrected overall inter-rater agreement was subtantial (0.6) according to Fleiss' multi-rater kappa and Gwet's AC1 statistics.Conclusion: This multi-center validation study identified the lack of preparation of accurate and consistent protein standards as the main reason for a poor inter-laboratory CV. This issue is also relevant to other protein biomarkers based on this type of assay and will need to be solved in order to achieve an acceptable level of analytical accuracy. The raw data of this study is available online. (C) 2009 Elsevier B.V. All rights reserved.

Type: Article
Title: Neurofilament ELISA validation
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.jim.2009.09.014
Keywords: Neurofilament, NfL, NF-L, NEFL, Biomarker, Validation, NEUROCHEMICAL DEMENTIA DIAGNOSTICS, CEREBROSPINAL-FLUID, ALZHEIMERS-DISEASE, MULTIPLE-SCLEROSIS, MARKERS, CSF, DEGENERATION, SUBUNIT, PROTEIN, ASSAYS
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
URI: https://discovery.ucl.ac.uk/id/eprint/95615
Downloads since deposit
669Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item